These mutations have been observed across various cancer types, but they seem to present a distinct pattern in EC, strengthening the hypothesis that ECs exhibit a unique spectrum of somatic mutations in the PIK3CA gene, particularly in the amino-terminal domain of p110-α. This evidence concerns the gene PIK3CA and cancer.